When a popular industrial enzyme promotes bacterial virulence

When a popular industrial enzyme promotes bacterial virulence
Like

The discovery of Lytic Polysaccharide Monooxygenases (LPMOs) in 2010 (1) received considerable attention and made a large impact in the field of biomass degradation due to their importance in the enzymatic conversion of chitin and cellulose. Prior to then the canonical enzymatic machineries involved in degradation of recalcitrant polysaccharides mostly contained hydrolytic enzymes. LPMOs revolutionized design of industrial enzyme cocktails, as these unique copper-containing redox enzymes employ powerful oxidative chemistry to cleave the glycosidic bonds of polysaccharides and work in synergy with glycoside hydrolases.

How are LPMOs connected to bacterial pathogenesis? These proteins were formerly considered “chitin binding proteins” (CBPs) as several contained auxiliary chitin-binding domains. “CBP” encoding genes were found in numerous bacterial genomes and while their function was unknown, a role in chitin catabolism rather than pathogenesis was suspected. However, several intriguing -omics analyses reported their upregulation upon interaction with host components such as blood, urine or sputum, providing a potential linkage to virulence (reviewed in 2). Indeed, prior to its recognition as an enzymatically functional LPMO, Vibrio cholerae GbpA was implicated in host colonization (3).

 Encouraged by these hints in the literature, we launched a project in 2018 to unravel the role of LPMOs in pathogenesis, placing our top priority on the multidrug-resistant opportunistic human pathogen Pseudomonas aeruginosa. The LPMO expressed by P. aeruginosa is called “chitin-binding protein D” (CbpD), and data suggesting it could play a role in virulence were so far circumstantial. We employed our complementary expertise in wet- and dry-lab technology in an interdisciplinary manner to explore the molecular determinants of this unique copper-dependent redox enzyme that impact colonization vs. invasive infection by P. aeruginosa. In our study, we show that secreted CbpD indeed is a catalytically competent LPMO that provides a strong pathogenicity phenotype and proteome re-organization in the context of systemic infection. Thus, LPMO function is not restricted to polysaccharide degradation, and our in-depth functional analyses revealed CbpD to attenuate the lytic mechanism of complement, allowing the pathogen to resist innate immune clearance in blood. Orthologs of CbpD are found in many Gram-negative and Gram-positive pathogens, including Vibrio cholerae and Enterococcus faecium, suggesting a potential common function of LPMOs in bacterial immune evasion.

 The prospect of effective solutions to counter the expanding antimicrobial resistance crisis has increasingly fallen on innovative basic and translational research. Given the particular importance of CbpD for P. aeruginosa, these proteins may be considered promising vaccine antigens or targets for combating infections through the emerging concept anti-virulence therapeutics.  By rendering the organism more sensitive to complement clearance, the potential may exist to treat P. aeruginosa with reduced antibiotic pressure for resistance evolution and less collateral damage to the healthy microbiota.  

 REFERENCES

1. Vaaje-Kolstad, G. et al. An oxidative enzyme boosting the enzymatic conversion of recalcitrant polysaccharides. Science 330, 219-222, doi:10.1126/science.1192231 (2010).

2. Agostoni, M., Hangasky, J. A. & Marletta, M. A. Physiological and molecular understanding of bacterial polysaccharide monooxygenases. Microbiol Mol Biol R 81, doi:10.1128/MMBR.00015-17 (2017).

3. Kirn, T. J., Jude, B. A. & Taylor, R. K. A colonization factor links Vibrio cholerae environmental survival and human infection. Nature 438, 863-866, doi:10.1038/nature04249 (2005).

 

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Microbiology
Life Sciences > Biological Sciences > Microbiology

Related Collections

With collections, you can get published faster and increase your visibility.

Biomedical applications for nanotechnologies

Overall, there are still several challenges on the path to the clinical translation of nanomedicines, and we aim to bridge this gap by inviting submissions of articles that demonstrate the translational potential of nanomedicines with promising pre-clinical data.

Publishing Model: Open Access

Deadline: Dec 31, 2023

Clinical research

Nature Communications is interested in publishing high-quality clinical research in all areas of clinical medicine. In this collection, we highlight some of the latest clinical research papers published in the journal.

Publishing Model: Open Access

Deadline: Ongoing